Cabaletta Bio (NASDAQ:CABA) 주식

Cabaletta Bio

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Prescription Drugs

Equities

Markets

CABA

카발레타 바이오(NASDAQ:CABA)의 주가는 수요일 24.38% 상승한 3.01달러에 마감했으며, 전신 경화증(Systemic Sclerosis) 약물 시험 업데이트 이후 시간외 거래에서 4.65% 상승한 주당 3.15달러에 거래되었다.

카발레타 바이오, 전신 경화증 약물 시험 업데이트 이후 수요일 23개월 만에 최대 급등

Cabaletta Bio Inc

Cabana Target Beta ETF

Cabana Target Drawdown 10 ETF

Cabana Target Leading Sector Moderate ETF

Finance maven, Aswath Damodaran, has highlighted against a simplistic interpretation of &#8220;buying the dip&#8221; in his latest blog post, underscoring how this contrarian investing strategy could not always benefit the investors without a thoughtful approach.
What Happened: The professor of finance at the Stern School of Business in New York University, Damodaran, has dissected the various paths to taking on contrarian bets while cautioning investors against simply buying every downward price movement without understanding the narrative.
Buying the dip could be &#8220;akin to catching a falling knife,&#8221; explains Damodaran, as initial market drop can be a prelude to a much larger sell-off off with there may be no near-term bounce back.
Instead of a one-size-fits-all approach, Damodaran outlines several distinct paths for contrarian investors:
<ul>
<li>The Value Contrarian: Focuses on fundamentally undervalued companies unfairly punished by the market, patiently buying dips in sound businesses for long-term value recognition.</li>
<li>The Sentiment Contrarian: Bets against widespread market pessimism, buying dips based on the belief that overreactions create opportunities, provided fundamentals remain intact.</li>
<li>The Catalyst-Driven Contrarian: Buys dips in companies facing temporary issues, anticipating a specific event will resolve the problems and trigger a market re-evaluation.</li>
</ul>
See Also: <a style="font-weight: bold;" href="https://www.benzinga.com/25/04/44891949/chinese-commerce-ministry-pledges-retaliation-against-countries-isolating-beijing-with-us-at-the-expense-of-chinas-interests">Xi Jinping&#8217;s China Pledges Retaliation Against Countries Isolating Beijing By Giving Into Trump Administration&#8217;s &#8216;Unilateral Bullying</a><a href="https://www.benzinga.com/25/04/44891949/chinese-commerce-ministry-pledges-retaliation-against-countries-isolating-beijing-with-us-at-the-expense-of-chinas-interests">&#8216;</a>
Why It Matters: Damodaran thinks that buying when the markets are falling takes &#8220;a mindset, a time horizon, and a stronger stomach&#8221; than most people have.
&#8220;Buying when the rest of the market is selling takes a mindset, a time horizon, and a stronger stomach than most of us do not have,&#8221; he adds.
Furthermore, he stressed the importance of due diligence and conviction. Contrarian investing requires rigorous research to understand the underlying business, its financials, and the reasons for the market&#8217;s negative perception.
Without this conviction, investors are likely to panic and sell at the first sign of further decline, negating the potential benefits of their contrarian bet.
Lastly, leveraging a long-term view and risk tolerance, Damodaran said that he has initiated limit buy orders for BYD, MercadoLibre Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>), and Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), which he aims to add to his portfolio. His BYD order was triggered on April 7th at under $80, while orders for Palantir and Mercado Libre remain active.
Price Action: By Thursday&#8217;s market close, the S&amp;P 500 had fallen 14.1% from its record high of 6,147.43. The Dow Jones was down 13.15% from its 52-week peak, and the Nasdaq 100 had dropped 17.84% from its high.
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, ended on a mixed note on Thursday. The SPY was up 0.14% to $526.41, while the QQQ declined 0.018% to $444.10, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pr</a>o data.
On Monday, the futures of Dow Jones, S&amp;P 500, and the Nasdaq 100 indices were down 0.71%, 0.68%, and 0.70%, respectively, at the time of writing.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/04/44880321/scott-bessent-says-china-wont-weaponize-us-treasuries-citing-risk-to-rmb-and-exports-we-do-buybacks" target="_blank" rel="noreferrer noopener">Scott Bessent Says China Won't ‘Weaponize' US Treasuries, Citing Risk To RMB And Exports: ‘We Do Buybacks'</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Analyst Color

News

General

MELI

PLTR

Dean Of Valuation Aswath Damodaran Warns Buying The Dip Akin To Catching A Falling Knife, Says It Takes A 'Stronger Stomach' Than Most Have

Kasikornbank Public (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KPCPY#OTC">KPCPY</a>) reported quarterly earnings of $0.68 per share. This is a 9.68 percent increase over earnings of $0.62 per share from the same period last year. The company reported $1.45 billion in sales this quarter. This is a 3.06 percent increase over sales of $1.41 billion the same period last year.

Earnings

KPCPY

Kasikornbank Public Q1 EPADS $0.68 Up From $0.62 YoY, Sales $1.45B Up From $1.41B YoY

Former Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) chief executive Eric Schmidt says Beijing's sudden surge in artificial‑intelligence spending could vault China past the United States unless Washington redoubles its efforts — and he's urging President Donald Trump to do more than scrap his predecessor's policies.
What Happened: "As a result of the incredible success of DeepSeek, the Chinese government … has decided this is another national priority. They're pouring billions of dollars into this," Schmidt told tech investor Ameer&nbsp;Haj‑Ali during an online chat.
"So never underestimate the Chinese competition here." He added a blunt warning: "China is going to win this race … unless we get our act together."
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Former Google CEO: &quot;China Will Win AI Race Unless We Act Now&quot; &#x7C; Founder Psychology, Talent Wars, AI" width="500" height="281" src="https://www.youtube.com/embed/DI-LKs3GpeE?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
See also: <a href="https://www.benzinga.com/markets/25/04/44892201/2025-largely-doesnt-matter-for-tesla-says-gene-munster-elon-musk-company-poised-for-a-major-rebound-in-2026-and-beyond">2025 &#8216;Largely Doesn&#8217;t Matter&#8217; For Tesla, Says Gene Munster: Elon Musk Company Poised &#8216;For A Major Rebound In 2026 And Beyond&#8217;</a>
Trump has already revoked President Joe Biden's <a href="https://www.benzinga.com/news/large-cap/25/01/43106379/trump-reverses-bidens-ai-policies-on-day-1-what-it-means-for-tech-giants-nvidia-amd-alphabet">2023 AI‑safety order</a> and signed a new directive, as <a href="https://apnews.com/article/trump-ai-artificial-intelligence-executive-order-eef1e5b9bec861eaf9b36217d547929c?utm_source=chatgpt.com">reported</a> by AP, pledging to build systems "free from ideological bias." The President has since tightened <a href="https://www.benzinga.com/news/global/25/04/44828742/nvidia-stock-is-tumbling-after-hours-heres-why">export bans</a> on AI chips to China that cost NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) an estimated $5.5 billion in sales.
Schmidt argued that any U.S. strategy must embed democratic norms. "It's imperative that the winner in AI win using American values and not Chinese values," he said. "The American traditionally liberal values of freedom of speech, freedom of expression, freedom of movement … would be forgotten" if China sets the rules.
Why It Matters: Schmidt&#8217;s China warning arrives amid a growing debate on U.S.-China relations and the control of AI technologies. Former Facebook exec and well-known investor Chamath Palihapitiya over the weekend <a href="https://www.benzinga.com/markets/25/04/44891778/nvidia-not-acting-in-us-interests-says-chamath-palihapitiya-questions-how-alibaba-or-deepseek-are-one-step-ahead">accused Nvidia</a> of not acting in the best interest of the U.S., alleging the chipmaker&#8217;s efforts to bypass export controls.
In February, reports revealed that Chinese tech giants Tencent Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCEHY#OTC">TCEHY</a>), Alibaba Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), and ByteDance <a href="https://www.benzinga.com/25/02/43931074/chinese-tech-giants-like-tencent-alibaba-and-bytedance-rush-to-buy-nvidias-h20-ai-chips-as-deepseeks-low-cost-models-fuel-massive-demand-surge">increased</a> their orders for Nvidia&#8217;s H20 AI chips, spurred by the rise of DeepSeek's cost-efficient AI models.
Photo Courtesy: Frederic Legrand &#8211; COMEO on Shutterstock.com
Read next: <a href="https://www.benzinga.com/tech/25/04/44892181/tim-cook-says-hiking-at-national-parks-one-of-his-favorite-things-to-do-but-rangers-struggling-with-staffing-cuts">Tim Cook Says Hiking At National Parks One Of His &#8216;Favorite Things To Do&#8217; But Rangers Struggling With Staffing Cuts</a>

Tech

BABA

GOOG

GOOGL

NVDA

TCEHY

Eric Schmidt Warns 'China Is Going To Win' AI Race Unless Washington Fights With Funding And Instills 'American Values' At The Core

In a recent post on Truth Social, President Donald Trump defended his stance on tariffs and outlined a list of 8 non-tariff practices that countries resort to.
What Happened: Trump, in a Truth Social post on Sunday, outlined a series of practices he labels as &#8220;non-tariff cheating.&#8221; This includes currency manipulation, VATs acting as tariffs, export subsidies, and protective agricultural standards, among others. He also pointed out counterfeiting, piracy, and IP theft, which according to him cost over $1 trillion annually.
Trump criticized business leaders who oppose tariffs in another post, stating, &#8220;The&nbsp;businessmen who criticize tariffs are&nbsp;bad at business, but really&nbsp;bad at politics.&#8221; He further asserted that he is the &#8220;greatest friend that American capitalism&nbsp;has ever had.&#8221;
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="608" height="394" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21031045/image-34.png" alt="" class="wp-image-879061" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21031045/image-34.png 608w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21031045/image-34-300x194.png 300w" sizes="(max-width: 608px) 100vw, 608px" /></figure>
Trump also mentioned the proclamation of &#8220;LIBERATION DAY,&#8221; stating that numerous world leaders and business executives have sought his help for relief from tariffs. He stressed the importance of other countries rectifying the &#8220;wrongs of decades of abuse,&#8221; and urged businesses to establish themselves in America.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/25/04/44890554/there-is-complete-meltdown-in-the-building-defense-secretary-loses-four-key-staffers-in-a-single-day" target="_blank" rel="noreferrer noopener">‘There Is Complete Meltdown in the Building': Defense Secretary Loses Four Key Staffers in a Single Day &#8211; Benzinga</a>
Why It Matters: Trump's support for tariffs is a key part of his economic policy, which he defends as a way to counter non-tariff barriers (like quotas, safety standards, and licensing rules) that he says unfairly restrict U.S. exports.
However, it has been found that not just other countries but even the U.S. frequently employs a protectionist measure known as the tariff-rate quota (TRQ) on imports. The TRQ functions more like a non-tariff barrier, as it doesn&#8217;t directly impose duties.
A 2024 study by the St. Louis Federal Reserve found that non-tariff barriers (NTBs) affect over two-thirds of U.S. imports—ranging from components to finished goods—across 15 manufacturing sectors, as reported by Fortune. The study underscores significant differences between tariffs and NTBs across industries and concludes that NTBs are widespread in all sectors of U.S. imports.
&#8220;&#8230;these nations charge the U.S. only slightly higher tariffs than the U.S. levies on their exports, and heap on far fewer non-tariff barriers than we do,&#8221; stated <a href="https://fortune.com/2025/04/16/trump-tariffs-non-tariff-barriers-most-protectionist-nations/">Fortune&#8217;s</a> Shawn Tully. &#8220;Trump's best solution would be offering to lower those NTBs that raise prices for American consumers and hobble our productivity in exchange for our trading partners' agreement to lower their restrictions,&#8221; added Tully.
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/markets/25/04/44891778/nvidia-not-acting-in-us-interests-says-chamath-palihapitiya-questions-how-alibaba-or-deepseek-are-one-ste" target="_blank" rel="noreferrer noopener">Nvidia Not Acting In US Interests, Says Chamath Palihapitiya — Questions, How Alibaba Or DeepSeek Are One Step Ahead</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Trump Defends Tariffs, Lists 'Non-Tariff Cheating' Tactics Like Currency Manipulation And IP Theft — Calls Himself The 'Greatest Friend' Of American Capitalism

Gene Munster, the Managing Partner of Deepwater Asset Management, predicts a major rebound for Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) in 2026, despite expecting a dip in the company&#8217;s earnings per share (EPS) and revenue estimates for the year.
What Happened: Munster suggests that Tesla&#8217;s 2025 performance is largely irrelevant to investors. He believes that the year is setting the stage for a significant recovery in 2026 and beyond. Munster anticipates a 10% decline in deliveries, which make up about 75% of Tesla&#8217;s business, in 2025. However, he predicts a 35% growth in deliveries in 2026, supported by an improving EV outlook, a healing brand,&nbsp;and the launch of a&nbsp;new model, according to a report by&nbsp;<a href="https://deepwatermgmt.com/tesla-march-preview-2025-largely-doesnt-matter/">Deepwater Management</a>.
In a post on X on Friday, Gene Munster stated, &#8220;Elon's message last quarter was that it's all about 2026, and I'd expect he doubles down on that.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24TSLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TSLA</a> earnings are next Tuesday. Elon's message last quarter was that it's all about 2026, and I'd expect he doubles down on that. <a href="https://t.co/clGibeJSjP">https://t.co/clGibeJSjP</a>
&mdash; Gene Munster (@munster_gene) <a href="https://twitter.com/munster_gene/status/1913234811147190744?ref_src=twsrc%5Etfw">April 18, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Although revenue is expected to be soft and automotive gross margins may decline in 2025, Munster remains optimistic about Tesla&#8217;s long-term investment potential. He emphasizes Tesla&#8217;s potential to lead in physical-world AI, autonomy, and robotics as crucial drivers of its future success.
While the projected non-GAAP EPS for 2026 is still below the Street&#8217;s estimate, Munster emphasizes that Tesla&#8217;s earnings are more than sufficient&nbsp;to finance its transition to&nbsp;real-world AI and autonomy. He also highlights that Tesla concluded 2024 with $37 billion in cash, cash equivalents, and investments, offering further confidence in the company's financial stability.
&#8220;Elon will reaffirm his confidence that this transition is unfolding faster than most expect, and that Tesla's product lineup is well-positioned to lead throughout the coming decade,&#8221; stated the Deepwater Managing Partner. 
SEE ALSO:&nbsp;<a href="https://benzinga.com/analyst-ratings/analyst-color/25/04/44883642/peter-schiff-rings-alarm-after-foreign-investors-dump-6-5-billion-in-us-equities-in" target="_blank" rel="noreferrer noopener">Peter Schiff Rings Alarm After Foreign Investors Dump $6.5 Billion In US Equities In A Week, Quips &#8216;Trump Thought Tariffs Would Bring Capital Into America&#8217;</a>
Why It Matters: Tesla&#8217;s recent struggles include a <a href="https://www.benzinga.com/markets/25/04/44882075/tesla-reportedly-scales-back-cybertruck-production-shifts-workers-as-sales-plummet-the-parking-lot-keeps-getting-emptier">sales slump </a>and scaled-back Cybertruck production. This has led some analysts like Dan Ives of Wedbush to suggest that Elon Musk should <a href="https://www.benzinga.com/25/04/44891383/elon-musk-needs-to-leave-the-government-and-get-back-to-being-ceo-of-tesla-says-dan-ives-ahead-of-q1-earnings">refocus </a>on Tesla. Reports suggest that Musk's attention to DOGE has frustrated some investors, who feel it diverts his focus from Tesla. Meanwhile, recent talks indicate that his involvement with the government may soon end, possibly freeing him up to concentrate more on Tesla
However, despite a Q1 miss, analysts like Alexander Potter from Piper Sandler believe in Tesla&#8217;s future growth potential, especially from robotaxis and <a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44850615/teslas-future-growth-from-robotaxis-and-new-products-intact-despite-q1-miss-analyst">new products</a>. Munster&#8217;s predictions align with this optimistic outlook, suggesting that the current struggles are temporary and that a major rebound is on the horizon.
Tesla holds a momentum rating of 92.50% and a growth rating of 67.70%, according to&nbsp;<a href="https://www.benzinga.com/quote/TSLA" target="_blank" rel="noreferrer noopener">Benzinga's Proprietary Edge Rankings</a>. The Benzinga Growth metric evaluates a stock&#8217;s historical earnings and revenue expansion across multiple timeframes, prioritizing both long-term trends and recent performance. For an in-depth report on more stocks and insights into growth opportunities,&nbsp;<a href="https://www.benzinga.com/screener/top-momentum-stocks" target="_blank" rel="noreferrer noopener">sign</a>&nbsp;<a href="https://www.benzinga.com/screener/top-momentum-stocks" target="_blank" rel="noreferrer noopener">up for Benzinga Edge.</a>
Year-to-date, Tesla stock has lost more than 36%. On Thursday, it edged 0.07% lower on $241.37, as per <a href="https://pro.benzinga.com/dashboard">BenzingaPro</a>. 
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/25/04/44891715/tech-bull-says-time-ticking-for-trade-deals-as-earnings-season-gathers-steam-calls-nvidias-china-disclosure-a-gam" target="_blank" rel="noreferrer noopener">Tech Bull Says &#8216;Time Ticking&#8217; For Trade Deals As Earnings Season Gathers Steam, Calls Nvidia&#8217;s China Disclosure A Game Of Who Blinks First</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

TSLA

2025 'Largely Doesn't Matter' For Tesla, Says Gene Munster: Elon Musk Company Poised 'For A Major Rebound In 2026 And Beyond'

On Saturday, Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) CEO Tim Cook marked National Park Week by expressing his love for hiking, even as U.S. national parks face staffing shortages and budget cuts.
What Happened: Over the weekend, Cook took to X, formerly Twitter, and celebrated National Park Week, stating, "Hiking at our national parks is one of my favorite things to do, and Apple Maps has thousands of amazing trails and hikes to discover. Happy #NationalParkWeek!"
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Hiking at our national parks is one of my favorite things to do, and Apple Maps has thousands of amazing trails and hikes to discover. Happy <a href="https://twitter.com/hashtag/NationalParkWeek?src=hash&amp;ref_src=twsrc%5Etfw">#NationalParkWeek</a>! <a href="https://t.co/ar9C6BW1XL">pic.twitter.com/ar9C6BW1XL</a>
&mdash; Tim Cook (@tim_cook) <a href="https://twitter.com/tim_cook/status/1913653825652588793?ref_src=twsrc%5Etfw">April 19, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
National Park Week, which runs from April 19–27, 2025, aims to highlight the beauty and significance of America's national parks, from iconic landscapes to historic sites.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It&#8217;s Important: Cook's post came amid growing concerns about staffing issues within the National Park Service, which has faced challenges due to federal layoffs and a reduced workforce.
The NPS laid off around 1,000 employees in February 2025, just ahead of the peak season, exacerbating the agency's already strained operations.
According to NPS officials, the agency has seen a 15% decrease in full-time staff over the past decade, impacting park services such as reservations, clean-up, and educational programs, <a href="https://www.npr.org/2025/02/26/nx-s1-5307908/national-parks-layoffs-visitors-disruptions">reported</a> NPR.
A bit of relief came when the Donald Trump administration allowed the NPS to fill seasonal positions that had been frozen due to a federal hiring ban. This move permits the hiring of up to 7,700 seasonal workers, above the three-year average of 6,350 positions, the report noted.
Photo Courtesy: Laura Hutton on Shutterstock.com
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://benzinga.com/25/03/44554189/openai-and-microsoft-back-mcp-standard-in-major-shift-toward-interoperable-ai-agents-that-can-think-click-and-navigate-the-web-but-google-ceo-sundar-pichai-appears-to-be-mulling-over-it-in-shakespearean-fashion-to-mcp-or-not-to-mcp" target="_blank" rel="noreferrer noopener">OpenAI And Microsoft Back MCP Standard For Web-Surfing AI Agents; Google's Sundar Pichai Asks A Shakespearean Question</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

AAPL

Tim Cook Says Hiking At National Parks One Of His 'Favorite Things To Do' But Rangers Struggling With Staffing Cuts

Hesai Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) announced it will introduce a next-generation LiDAR system for Level 3 autonomous driving.
What Happened: According to Reuters, Hesai Group CEO David Li shared on Monday that the company will launch its updated LiDAR system in 2026.
Li says the new system will provide autonomous driving cars with &#8220;double&#8221; the detection distance of its current best-selling model, the AT128.
No further details or technical specifications were shared following the announcement. Hesai&#8217;s customers include several EV companies like Nio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>), XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>), as well as Aurora Innovation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) and Chinese autonomous vehicle company Pony AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>).
Why It Matters: The news comes in as development of autonomous driving is picking up speed, with companies like Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Waymo among the biggest players in the segment.
Tesla had recently shared the development of its <a href="https://www.benzinga.com/tech/25/04/44787364/tesla-deploys-unsupervised-fsd-at-giga-texas-to-move-cars-from-factory-to-lot">autonomous driving technology</a> via a post on the social media platform X, showcasing a Model 3 and a Cybertuck utilizing Full-Self Driving (FSD.)
Tesla CEO Elon Musk also <a href="https://www.benzinga.com/markets/equities/25/04/44834045/tesla-touts-fsd-capabilities-elon-says-predicts-cars-will-soon-drive-itself-right-to-your-house">made a prediction</a> that a Tesla vehicle would be able to drive to people's houses by itself, &#8216;this year,' in a post on X. However, it&#8217;s worth noting that Musk's company still utilizes a <a href="https://www.benzinga.com/25/03/44529187/elon-musk-says-tesla-doesnt-need-lidar-because-people-dont-shoot-lasers-out-of-their-eyes-yet-his-ev-company-quietly-spent-over-2-million-on-the-technology-in-2024-as-china-takes-global-lead">camera-based system</a> for its FSD, unlike Waymo, which opts for a LiDAR system instead.
Price Action: HSAI stock has declined more than 32.11% year-to-date, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Check out more of Benzinga's Future Of Mobility coverage by <a href="https://www.benzinga.com/topic/mobility">following this link</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44891383/elon-musk-needs-to-leave-the-government-and-get-back-to-being-ceo-of-tesla-says-dan-ives-ahead-of-q1-earnings">Elon Musk &#8216;Needs To Leave&#8217; The Government And Get Back To Being CEO Of Tesla, Says Dan Ives Ahead Of Q1 Earnings</a></li>
</ul>
Photo courtesy: Shutterstock

HSAI

PONY

XPEV

Nio, XPeng Supplier Hesai Group Announces Next-Gen LiDAR For Level 3 Autonomous Driving

FOUR

Reported Friday, Shift4 Extends Global Blue Tender Offer To May 6 As Minimum Condition And 96.42% Threshold Are Met

LITB

Reported Friday, LightInTheBox Transitions To Manufacturer-To-Consumer Model, Enhancing Efficiency And Competitive Pricing

VCSA

Reported Friday, Vacasa Special Committee Rejects Revised Davidson Kempner Proposal, Reaffirms Support For Casago Transaction

The CNN Money Fear and Greed index remained in the &#8220;Extreme Fear&#8221; zone on Friday.
U.S. stocks settled mostly lower on Thursday, with the Dow Jones index falling more than 500 points during the session. The 30-stock index recorded losses for the third day, while all three major indices closed the holiday-shortened trading week on a lower note.
UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) shares dipped over 22% on Thursday after the company reported worse-than-expected first-quarter results and cut its FY25 adjusted EPS guidance below estimates. Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares fell around 3% on Thursday, after declining around 7% in the previous session.
However, Eli Lilly &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) shares staged their sharpest single-day rally in nearly 25 years Thursday, after unveiling data from a pivotal trial that could cement its leadership in a weight-loss drug market projected to more than triple in size by 2030.
On the economic data front, U.S. housing starts dipped 11.4% month-over-month to an annualized rate of 1.324 million in March. U.S. initial jobless claims declined by 9,000 from the previous week to 215,000 during the second week of April, versus market estimates of 225,000. The Philadelphia Fed Manufacturing Index fell 39 points to a reading of -26.4 in April, and down from market estimates of 2.
Most sectors on the S&amp;P 500 closed on a positive note, with energy, consumer staples, and real estate stocks recording the biggest gains on Thursday. However, information technology and health care stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed lower by around 527 points to 39,142.23 on Thursday. The S&amp;P 500 rose 0.13% to 5,282.70, while the Nasdaq Composite fell 0.13% to 16,286.45 during Thursday's session.
Investors are awaiting earnings results from Zions Bancorporation, National Association (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>), AZZ Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>), and Comerica Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 20.9, the index remained in the &#8220;Extreme Fear&#8221; zone on Friday, versus a prior reading of 21.4.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next:
<ul>
<li> <a href="https://www.benzinga.com/25/04/44862261/top-3-materials-stocks-that-are-ticking-portfolio-bombs">Top 3 Materials Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo courtesy: Shutterstock

Pre-Market Outlook

Trading Ideas

ZION

Dow Dips Over 500 Points, Down For 3rd Straight Session As UnitedHealth Tanks: Greed Index Remains In 'Extreme Fear' Zone

Reported Friday, iQIYI Launches Second Immersive Theme Park In Kaifeng, Extending IP And AI-Powered Content Into Real-World Experiences

LDOS

Reported Friday, Leidos Invests $10M In Multi-Year AI Collaboration With University Of Pittsburgh To Transform Disease Diagnosis And Management

Through this partnership, Primo Brands is investing annually to support cleanup efforts in Los Angeles County. This collaboration underscores both organizations' commitment to creating a healthier environment and cleaner waterways.&nbsp;

PRMB

Reported Friday, Primo Brands Partners With The Ocean Cleanup To Expand Efforts For Cleaner Waterways In Los Angeles County

<ul>
<li>DESTINY-Breast09 phase 3 trial of Daiichi Sankyo and AstraZeneca's ENHERTU is the first trial in more than a decade to demonstrate superior efficacy across a broad HER2 positive metastatic patient population versus current first-line standard of care</li>
<li>Plans for regulatory submissions are underway</li>
</ul>

DSNKY

AstraZeneca And Daiichi Sankyo's ENHERTU Plus Pertuzumab Demonstrates Statistically Significant PFS Benefit In Phase 3 Trial

REGN

Reported Friday, Regeneron Receives FDA Complete Response On EYLEA HD Application, No Safety Or Efficacy Issues Identified

Chemung Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHMG#NASDAQ">CHMG</a>) reported quarterly earnings of $1.26 per share which missed the analyst consensus estimate of $1.31 by 3.82 percent. This is a 14.86 percent decrease over earnings of $1.48 per share from the same period last year. The company reported quarterly sales of $25.70 million which missed the analyst consensus estimate of $26.69 million by 3.71 percent. This is a 8.23 percent increase over sales of $23.75 million the same period last year.

Earnings Misses

CHMG

Reported Friday, Chemung Financial Q1 2025 GAAP EPS $1.26 Misses $1.31 Estimate, Sales $25.70M Miss $26.69M Estimate

Reported Friday, CNFinance Holdings Faces NYSE Compliance Issue Over Sub-$1.00 ADS Price, Plans Timely Response

Reported Friday, GrafTech Receives NYSE Notice For Non-Compliance With Continued Listing Standards

The hospital, expected to open in 2027, will be part of Encompass Health's national network of inpatient rehabilitation hospitals and its second location in Utah.

Reported Friday, Encompass Health Plans 50-Bed Rehab Hospital In St. George Featuring Advanced Therapies and Private Patient Rooms

Press Releases

Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024

Cabaletta Bio to Participate in Upcoming Investor Conferences in December

Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025

Cabaletta Bio to Participate in Guggenheim's SMID Cap Biotech Conference

Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February

Health Care

Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings

UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings

Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference

Cellares and Cabaletta Bio Successfully Complete Manufacturing Technology Adoption Program for Rese-cel Using the Cell Shuttle™ Platform

Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Comments

Cabaletta Bio

뉴스

파트너 / 기고자

벤징가 글로벌